Director/PDMR Dealing

RNS Number : 7843C
Kanabo Group PLC
25 February 2022
 

Kanabo Group Plc

("Kanabo" or the "Company")

 

Director/PDMR Dealing

 

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company focussing on the development and distribution of cannabis-derived products for medical patients and wellness CBD consumers, announces Daniel Poulter, Non- Executive Director, has purchased 55,000 ordinary shares at a price of 7.4p.

 

Avihu Tamir, CEO, commented: "Since joining Kanabo in June 2021 Dan has become an invaluable member of the board. I welcome his most recent show of support by acquiring shares in the market. With the recent acquisition of the GP Service, and completion of an oversubscribed fundraise, Kanabo has approximately £6.4m and is well positioned to implement its growth strategy".

 

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

 

For further information, please visit http://www.kanabogroup.com/ or contact the following:

Kanabo Group Plc

Via Vox Markets

Avihu Tamir, CEO

 

Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Lauren Riley

 

Peterhouse Capital Ltd (Corporate Broker)

Tel: +44 (0)20 7469 0930

Lucy Williams / Charles Goodfellow

Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Daniel Poulter

 

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

 

a)

 

Name

 

 

Kanabo Group Plc

b)

 

LEI

 

 

213800XPJFSNWJIYKN52

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2.5 pence each in Kanabo Group Plc

 

 

Identification code

GB00BYQCS703

 

 

b)

 

Nature of the transaction

 

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

7.4p

55,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

55,000

 

 

- Price

£4,053

 

 

e)

 

Date of the transaction

 

 

24/02/2022

f)

 

Place of the transaction

 

 

Standard List of the Main Market    

 

Following the share purchase, Mr Poulter's beneficial interests in the capital of the Company is 0.013%.

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers. It has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPUQPPUPPGBC

Companies

Kanabo Group (KNB)
UK 100

Latest directors dealings